Orally Disintegrating Tablet Market : Table of Content


  • Published On : Nov-2019 |
  • Pages : 179 Pages |
  • Format : Orally Disintegrating Tablet Market Orally Disintegrating Tablet Market Orally Disintegrating Tablet Market Orally Disintegrating Tablet Market

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Dynamics

    3.1. Macro-Economic Factors

    3.2. Drivers

        3.2.1. Supply Side Drivers 

        3.2.2. Demand Side Drivers

    3.3. Restraints

    3.4. Opportunities

    3.5. Trends

4. Key Inclusion

    4.1. Formulation processes for Orally Disintegrating Tablets 

    4.2. Value Chain Analysis

5. Global Orally Disintegrating Tablets Market Value Analysis 2014-2018 and Forecast, 2019-2029

    5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

    5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

        5.2.1. Y-o-Y Growth Trend Analysis

        5.2.2. Absolute $ Opportunity Analysis

6. Global Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class 

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 - 2029

        6.3.1. Anti-Psychotics

        6.3.2. Anti-Epileptic’s

        6.3.3. CNS Stimulants

        6.3.4. Anxiolytics

        6.3.5. Anti-Parkinson Ian Drugs

        6.3.6. Anti-Hypertensives

        6.3.7. NSAIDS

        6.3.8. Anti-Allergy Drugs

        6.3.9. Proton Pump Inhibitor

        6.3.10. Others

    6.4. Market Attractiveness Analysis By Drug Class 

7. Global Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029, by Disease Indication

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2014-2018

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2019 - 2029

        7.3.1. Central Nervous System Diseases (CNS)

        7.3.2. Gastrointestinal (GI) Diseases 

        7.3.3. Cardiovascular(CVS) Diseases

        7.3.4. Allergy 

        7.3.5. Others

    7.4.  Market Attractiveness Analysis By Disease Indication

8. Global Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029

        8.3.1. Hospital Pharmacy 

        8.3.2. Retail Pharmacy 

        8.3.3. Drug Stores

        8.3.4. Online Pharmacy

    8.4.  Market Attractiveness Analysis By Distribution Channel

9. Global Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029, by Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

    9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia-Pacific

        9.3.5. Middle East & Africa

    9.4.  Market Attractiveness Analysis By Region

10. North America Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        10.3.1. By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By Drug Class

        10.3.3. By Disease Indication 

        10.3.4. By Distribution Channel

    10.4. Market Attractiveness Analysis

    10.5. Drivers & Restraints: Impact Analysis

    10.6. Partial List of Players with Product Intensity Map By Country

11. Latin America Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        11.3.1. By Country

            11.3.1.1. Brazil

            11.3.1.2. Mexico

            11.3.1.3. Rest of Latin America

        11.3.2. By Drug Class

        11.3.3. By Disease Indication 

        11.3.4. By Distribution Channel

    11.4. Market Attractiveness Analysis 

    11.5. Drivers & Restraints: Impact Analysis

    11.6. Partial List of Players with Product Intensity Map By Country

12. Europe Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        12.3.1. By Country

            12.3.1.1. Germany

            12.3.1.2. U.K.

            12.3.1.3. France

            12.3.1.4. Italy

            12.3.1.5. Spain

            12.3.1.6. Russia

            12.3.1.7. Rest of Europe

        12.3.2. By Drug Class

        12.3.3. By Disease Indication 

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis 

    12.5. Drivers & Restraints: Impact Analysis

    12.6. Partial List of Players with Product Intensity Map By Country

13. Asia-Pacific Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        13.3.1. By Country

            13.3.1.1. China

            13.3.1.2. India

            13.3.1.3. Japan

            13.3.1.4. Australia & New Zealand

            13.3.1.5. Rest of Asia-Pacific 

        13.3.2. By Drug Class

        13.3.3. By Disease Indication 

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis 

    13.5. Drivers & Restraints: Impact Analysis

    13.6. Partial List of Players with Product Intensity Map By Country

14. Middle East and Africa Orally Disintegrating Tablets Market Analysis 2014-2018 and Forecast 2019-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

        14.3.1. By Country

            14.3.1.1. GCC Countries

            14.3.1.2. South Africa

            14.3.1.3. Rest of MEA

        14.3.2. By Drug Class

        14.3.3. By Disease Indication 

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis 

    14.5. Drivers & Restraints: Impact Analysis

    14.6. Partial List of Players with Product Intensity Map By Country

15. Competition Analysis

    15.1. Company Share Analysis

    15.2. Market Structure by Tier of Companies

    15.3. Competition Dashboard

    15.4. Competition Deep Dive 

        15.4.1. Teva Pharmaceutical Industries Ltd.

            15.4.1.1. Company Overview

            15.4.1.2. Segment Overview

            15.4.1.3. Product Offerings

            15.4.1.4. Financial Analysis

            15.4.1.5. Key Developments

            15.4.1.6. Strategy Overview

        15.4.2. Novartis AG

            15.4.2.1. Company Overview

            15.4.2.2. Segment Overview

            15.4.2.3. Product Offerings

            15.4.2.4. Financial Analysis

            15.4.2.5. Key Developments

            15.4.2.6. Strategy Overview

        15.4.3. AstraZeneca

            15.4.3.1. Company Overview

            15.4.3.2. Segment Overview

            15.4.3.3. Product Offerings

            15.4.3.4. Financial Analysis

            15.4.3.5. Key Developments

            15.4.3.6. Strategy Overview

        15.4.4. Mylan N.V.

            15.4.4.1. Company Overview

            15.4.4.2. Segment Overview

            15.4.4.3. Product Offerings

            15.4.4.4. Financial Analysis

            15.4.4.5. Key Developments

            15.4.4.6. Strategy Overview

        15.4.5. Pfizer Inc.

            15.4.5.1. Company Overview

            15.4.5.2. Segment Overview

            15.4.5.3. Product Offerings

            15.4.5.4. Financial Analysis

            15.4.5.5. Key Developments

            15.4.5.6. Strategy Overview

        15.4.6. Johnson & Johnson Services, Inc.

            15.4.6.1. Company Overview

            15.4.6.2. Segment Overview

            15.4.6.3. Product Offerings

            15.4.6.4. Financial Analysis

            15.4.6.5. Key Developments

            15.4.6.6. Strategy Overview

        15.4.7. F. Hoffmann-La Roche Ltd.

            15.4.7.1. Company Overview

            15.4.7.2. Segment Overview

            15.4.7.3. Product Offerings

            15.4.7.4. Financial Analysis

            15.4.7.5. Key Developments

            15.4.7.6. Strategy Overview

        15.4.8. Merck & Co., Inc.

            15.4.8.1. Company Overview

            15.4.8.2. Segment Overview

            15.4.8.3. Product Offerings

            15.4.8.4. Financial Analysis

            15.4.8.5. Key Developments

            15.4.8.6. Strategy Overview

        15.4.9. Bausch Health

            15.4.9.1. Company Overview

            15.4.9.2. Segment Overview

            15.4.9.3. Product Offerings

            15.4.9.4. Financial Analysis

            15.4.9.5. Key Developments

            15.4.9.6. Strategy Overview

        15.4.10. GlaxoSmithKline plc.

            15.4.10.1. Company Overview

            15.4.10.2. Segment Overview

            15.4.10.3. Product Offerings

            15.4.10.4. Financial Analysis

            15.4.10.5. Key Developments

            15.4.10.6. Strategy Overview

        15.4.11. Sun Pharmaceutical Industries Ltd.

            15.4.11.1. Company Overview

            15.4.11.2. Segment Overview

            15.4.11.3. Product Offerings

            15.4.11.4. Financial Analysis

            15.4.11.5. Key Developments

            15.4.11.6. Strategy Overview

        15.4.12. Bayer AG

            15.4.12.1. Company Overview

            15.4.12.2. Segment Overview

            15.4.12.3. Product Offerings

            15.4.12.4. Financial Analysis

            15.4.12.5. Key Developments

            15.4.12.6. Strategy Overview

        15.4.13. Eli Lily and Company

            15.4.13.1. Company Overview

            15.4.13.2. Segment Overview

            15.4.13.3. Product Offerings

            15.4.13.4. Financial Analysis

            15.4.13.5. Key Developments

            15.4.13.6. Strategy Overview

        15.4.14. Dr. Reddy’s Laboratories Ltd.

            15.4.14.1. Company Overview

            15.4.14.2. Segment Overview

            15.4.14.3. Product Offerings

            15.4.14.4. Financial Analysis

            15.4.14.5. Key Developments

            15.4.14.6. Strategy Overview

        15.4.15. Takeda Pharmaceutical Company Limited

            15.4.15.1. Company Overview

            15.4.15.2. Segment Overview

            15.4.15.3. Product Offerings

            15.4.15.4. Financial Analysis

            15.4.15.5. Key Developments

            15.4.15.6. Strategy Overview

16. Assumptions and Acronyms Used

17. Research Methodology


List of Tables:

Table 01: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Class

Table 02: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Disease Indication

Table 03: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 04: Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Region

Table 05: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 06: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Class

Table 07: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Disease Indication

Table 08: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 09: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 10: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Class

Table 11: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Disease Indication

Table 12: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 13: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 14: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Class

Table 15: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Disease Indication

Table 16: Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 17: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 18: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Class

Table 19: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Disease Indication

Table 20: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel

Table 21: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country

Table 22: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Drug Class

Table 23: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Disease Indication

Table 24: Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel


List of Figures:

Figure 01: Global Orally Disintegrating Tablets Market Split By Drug Class (2019E)

Figure 02: Global Orally Disintegrating Tablets Market Split By Disease Indication (2019E)

Figure 03: Global Orally Disintegrating Tablets Market Split By Distribution Channel (2019E)

Figure 04: Global Orally Disintegrating Tablets Market Split By Region (2019E)

Figure 05: Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2014–2018

Figure 06: Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2019–2029

Figure 07: Orally Disintegrating Tablets Market Absolute $ Opportunity, 2019–2029

Figure 08: Orally Disintegrating Tablets Market Share Analysis (%), By Drug Class, 2019 & 2029

Figure 09: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Drug Class, 2019–2029

Figure 10: Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class, 2019–2029

Figure 11: Orally Disintegrating Tablets Market Share Analysis (%), By Disease Indication, 2019 & 2029

Figure 12: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Disease Indication, 2019–2029

Figure 13: Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2019–2029

Figure 14: Orally Disintegrating Tablets Market Share Analysis (%), By Distribution Channel, 2019 & 2029

Figure 15: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Distribution Channel, 2019–2029

Figure 16: Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2019–2029

Figure 17: Orally Disintegrating Tablets Market Share Analysis (%), By Region, 2019 & 2029

Figure 18: Orally Disintegrating Tablets Market Y-o-Y Analysis (%), By Region, 2019–2029

Figure 19: Orally Disintegrating Tablets Market Attractiveness Analysis by Region, 2019–2029

Figure 20: North America Orally Disintegrating Tablets Market Value Share, By Drug Class, 2019 (E)

Figure 21: North America Orally Disintegrating Tablets Market Value Share, Disease Indication, 2019 (E)

Figure 22: North America Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2019 (E)

Figure 23: North America Orally Disintegrating Tablets Market Value Share, By Country, 2019 (E)

Figure 24: North America Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2014–2018

Figure 25: North America Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2019–2029

Figure 26: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2019–2029

Figure 27: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2019–2029

Figure 28: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2019–2029

Figure 29: North America Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2019–2029

Figure 30: Latin America Orally Disintegrating Tablets Market Value Share, By Drug Class, 2019 (E)

Figure 31: Latin America Orally Disintegrating Tablets Market Value Share, Disease Indication, 2019 (E)

Figure 32: Latin America Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2019 (E)

Figure 33: Latin America Orally Disintegrating Tablets Market Value Share, By Country, 2019 (E)

Figure 34: Latin America Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2014–2018

Figure 35: Latin America Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2019–2029

Figure 36: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2019–2029

Figure 37: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2019–2029

Figure 38: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2019–2029

Figure 39: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2019–2029

Figure 40: Europe Orally Disintegrating Tablets Market Value Share, By Drug Class, 2019 (E)

Figure 41: Europe Orally Disintegrating Tablets Market Value Share, Disease Indication, 2019 (E)

Figure 42: Europe Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2019 (E)

Figure 43: Europe Orally Disintegrating Tablets Market Value Share, By Country, 2019 (E)

Figure 44: Europe Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2014–2018

Figure 45: Europe Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2019–2029

Figure 46: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2019–2029

Figure 47: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2019–2029

Figure 48: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2019–2029

Figure 49: Europe Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2019–2029

Figure 50: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Drug Class, 2019 (E)

Figure 51: Asia-Pacific Orally Disintegrating Tablets Market Value Share, Disease Indication, 2019 (E)

Figure 52: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2019 (E)

Figure 53: Asia-Pacific Orally Disintegrating Tablets Market Value Share, By Country, 2019 (E)

Figure 54: Asia-Pacific Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2014–2018

Figure 55: Asia-Pacific Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2019–2029

Figure 56: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Drug Class, 2019–2029

Figure 57: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2019–2029

Figure 58: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Distribution Channel, 2019–2029

Figure 59: Asia-Pacific Orally Disintegrating Tablets Market Attractiveness Analysis by Country, 2019–2029

Figure 60: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Drug Class, 2019 (E)

Figure 61: Middle East & Africa Orally Disintegrating Tablets Market Value Share, Disease Indication, 2019 (E)

Figure 62: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Distribution Channel, 2019 (E)

Figure 63: Middle East & Africa Orally Disintegrating Tablets Market Value Share, By Country, 2019 (E)

Figure 64: Middle East & Africa Orally Disintegrating Tablets Market Value Analysis (US$ Mn), 2014–2018

Figure 65: Middle East & Africa Orally Disintegrating Tablets Market Value Forecast (US$ Mn), 2019–2029

Figure 66: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class, 2019–2029

Figure 67: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis by Disease Indication, 2019–2029

Figure 68: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel, 2019–2029

Figure 69: Middle East & Africa Orally Disintegrating Tablets Market Attractiveness Analysis, By Country, 2019–2029

Figure 70: Orally Disintegrating Tablets Market: Company Share Analysis Share Analysis (2019)

Orally Disintegrating Tablet Market - Table of Content

Back To Top